Get the Stockscreener App
96.39
1.53%
1.45
Invesco Biotechnology Genome Etf stock is traded at $96.39, with a volume of 1,295.
It is up +1.53% in the last 24 hours and up +2.94% over the past month.
See More
Previous Close:
$94.94
Open:
$94.75
24h Volume:
1,295
Relative Volume:
0.13
Market Cap:
$419.30M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+1.65%
1M Performance:
+2.94%
6M Performance:
+18.43%
1Y Performance:
+36.32%
1-Day Range:
$94.75
$96.39
1-Week Range:
$92.97
$96.90
52-Week Range:
$70.01
$98.82
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Name
Invesco Biotechnology Genome Etf
Sector
Industry
Phone
-
Address
-
Compare PBE vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
96.39 | 419.30M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
707.28 | 1.04T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
772.90 | 886.91B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
769.47 | 812.66B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
376.88 | 694.13B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
730.61 | 488.63B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Stock (PBE) Latest News
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Zacks Investment Research
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance UK
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Zacks Investment Research
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? - The Motley Fool
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? - The Globe and Mail
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? - Yahoo Finance
How Invesco Dynamic Biotechnology & Genome Etf (PBE) Affects Rotational Strategy Timing - Stock Traders Daily
ETFs Investing in Legend Biotech Corp. Sponsored ADR Stocks - TradingView
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets - Benzinga
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Eastern Progress
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? - The Motley Fool
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? - The Globe and Mail
7 Best Biotech ETFs to Buy Now | Investing - US News Money
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? - The Motley Fool
PBE | Invesco Biotechnology & Genome Insider Trading - Quiver Quantitative
Biotech ETF Showdown: Why a 251-Stock Basket Is Beating Concentrated Rivals - finance.biggo.com
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? - The Motley Fool
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Globe and Mail
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Motley Fool
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Globe and Mail
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? - Yahoo Finance
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Eastern Progress
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - The Motley Fool
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - Yahoo Finance
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - The Globe and Mail
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - NewsBreak: Local News & Alerts
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
XLV vs PBE: Healthcare Sector Stability vs Biotech Growth - sekbernews.id
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? - theglobeandmail.com
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? - The Motley Fool
PBE Dividend: 1.49% Yield, $1.55/Share — History & Dates - GuruFocus
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Gilead Sciences Inc (GILD) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Invesco Biotechnology & Genome ETF : PBE - 24/7 Wall St.
Biotech ETFs XBI and PBE diverge sharply in str... - Pluang
ETF Showdown: XBI vs PBE, Which Biotech Fund Wins? - Yahoo Finance
ETF Showdown: XBI vs PBE, Which Biotech Fund Wins? - 24/7 Wall St.
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.com
PBEInvesco Biotechnology & Genome ETF Earnings - Finviz
PBEInvesco Biotechnology & Genome ETF Volatility & Greeks - Finviz
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Invesco Biotechnology Genome Etf Stock (PBE) Financials Data
There is no financial data for Invesco Biotechnology Genome Etf (PBE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):